source
- Trump administration’s MFN drug pricing deals may cut projected Medicare savings by up to 80%The White House announced "most-favored-nation" pricing agreements with 26 pharmaceutical companies, saying the contracts would lower drug costs for federal programs. The deals require companies to…
- FDA issues rule to allow non-animal testing methods for drug safetyFDA issued a direct final rule that updates its regulations to clarify that non-animal methods may be used for safety testing of drugs and biological products before they are tested in humans. The…